JP2023546725A5 - - Google Patents

Info

Publication number
JP2023546725A5
JP2023546725A5 JP2023525078A JP2023525078A JP2023546725A5 JP 2023546725 A5 JP2023546725 A5 JP 2023546725A5 JP 2023525078 A JP2023525078 A JP 2023525078A JP 2023525078 A JP2023525078 A JP 2023525078A JP 2023546725 A5 JP2023546725 A5 JP 2023546725A5
Authority
JP
Japan
Prior art keywords
cancer
amino acid
domain
cells
chimeric protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023525078A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023546725A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/027294 external-priority patent/WO2022093310A1/en
Publication of JP2023546725A publication Critical patent/JP2023546725A/ja
Publication of JP2023546725A5 publication Critical patent/JP2023546725A5/ja
Pending legal-status Critical Current

Links

JP2023525078A 2020-10-26 2021-04-14 ブチロフィリンを含むホモ二量体及びヘテロ二量体タンパク質 Pending JP2023546725A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063105744P 2020-10-26 2020-10-26
US63/105,744 2020-10-26
PCT/US2021/027294 WO2022093310A1 (en) 2020-10-26 2021-04-14 Homodimeric and heterodimeric proteins comprising butyrophilin

Publications (2)

Publication Number Publication Date
JP2023546725A JP2023546725A (ja) 2023-11-07
JP2023546725A5 true JP2023546725A5 (cg-RX-API-DMAC7.html) 2024-04-24

Family

ID=81384237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023525078A Pending JP2023546725A (ja) 2020-10-26 2021-04-14 ブチロフィリンを含むホモ二量体及びヘテロ二量体タンパク質

Country Status (7)

Country Link
US (1) US20230416333A1 (cg-RX-API-DMAC7.html)
EP (1) EP4232065A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023546725A (cg-RX-API-DMAC7.html)
CN (1) CN116801897A (cg-RX-API-DMAC7.html)
AU (1) AU2021370788A1 (cg-RX-API-DMAC7.html)
CA (1) CA3196533A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022093310A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024511992A (ja) * 2021-03-16 2024-03-18 シャタック ラボ,インコーポレイテッド ガンマデルタt細胞刺激
WO2023102617A1 (en) * 2021-12-09 2023-06-15 The University Of Melbourne Modified butyrophilin and butyrophilin complexes
WO2024006889A2 (en) * 2022-06-29 2024-01-04 Shattuck Labs, Inc. Cd20-targeted gamma delta t cell modulation
WO2024006907A2 (en) * 2022-06-29 2024-01-04 Shattuck Labs, Inc. B7h3-targeted gamma delta t cell modulation
CN118388647A (zh) * 2022-06-30 2024-07-26 深圳市乐土生物医药有限公司 一种分离的Claudin18.2抗体及其应用
WO2024123812A1 (en) 2022-12-05 2024-06-13 Shattuck Labs, Inc. Fusion proteins for the treatment of cardiometabolic diseases
CN121752279A (zh) * 2023-06-30 2026-03-27 科瑞特医药公司 工程化嵌合融合蛋白组合物及其使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201913573UA (en) * 2015-10-01 2020-03-30 Heat Biologics Inc Compositions and methods for adjoining type i and type ii extracellular domains as heterologous chimeric proteins
WO2020047329A1 (en) * 2018-08-29 2020-03-05 Shattuck Labs, Inc. Chimeric proteins comprising extracellular domains and uses thereof
BR112021013193A2 (pt) * 2019-01-07 2021-09-28 Shattuck Labs, Inc. Proteínas heterodiméricas para modulação de células t gama delta

Similar Documents

Publication Publication Date Title
Jin et al. Emerging new therapeutic antibody derivatives for cancer treatment
JP2024059628A (ja) Cd19指向性キメラ抗原受容体および免疫療法におけるその使用
JP2022516964A5 (cg-RX-API-DMAC7.html)
JP7438958B2 (ja) 新規な抗体分子、その調製方法及びその使用
JP2020530299A5 (cg-RX-API-DMAC7.html)
JP2024500847A5 (cg-RX-API-DMAC7.html)
CN114072427A (zh) 抗dll3嵌合抗原受体及其用途
JP2019523630A5 (cg-RX-API-DMAC7.html)
JP2020530298A5 (cg-RX-API-DMAC7.html)
JP2020506727A5 (cg-RX-API-DMAC7.html)
CN107636015A (zh) 包含结合蛋白和对IL‑15Rα具有降低亲和力的白介素‑15多肽的融合蛋白及其治疗用途
RU2018139339A (ru) Новые биспецифические полипептиды против cd137
JP2020530989A5 (cg-RX-API-DMAC7.html)
WO2018177371A1 (en) Antigen-specific t cells and uses thereof
JP2022549186A5 (cg-RX-API-DMAC7.html)
WO2018119118A4 (en) Lymphotoxin-beta receptor-binding agents, targeting antibodies, and uses thereof
JP2023512452A (ja) Bcma指向性細胞免疫療法組成物および方法
JP2024519335A (ja) がん免疫療法のための投薬レジメン
JP2024525727A5 (cg-RX-API-DMAC7.html)
CN115698088A (zh) 免疫细胞衔接器多特异性结合蛋白及其制备和应用
JP2024522949A5 (cg-RX-API-DMAC7.html)
CN113490690A (zh) 异源二聚体融合蛋白
JP2023534959A5 (cg-RX-API-DMAC7.html)
JP2024543043A5 (cg-RX-API-DMAC7.html)
JP2019505545A5 (cg-RX-API-DMAC7.html)